Source link : https://newshealth.biz/health-news/early-relapse-signals-high-risk-primary-refractory-lbcl/
A secondary analysis of a phase 3 trial suggests that patients with relapse within 3 months of treatment or persistent disease represent a distinct high-risk group. Medscape Medical News Source link : https://www.medscape.com/viewarticle/early-relapse-signals-high-risk-primary-refractory-lbcl-2026a1000as0?src=rss Author : Publish date : 2026-04-09 05:09:00 Copyright for syndicated content belongs to the linked Source.
The post Early Relapse Signals High-Risk Primary Refractory LBCL first appeared on News Health.
—-
Author : News Health
Publish date : 2026-04-09 05:09:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8